- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05497154
Physical Therapists Identifying Patients With Opioid Misuse
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
The purpose of this study is to develop and operationalize key procedures for physical therapists (n = 12) to address patients who are at risk for or have OM. The investigators will train physical therapists in procedures to: 1) engage patients at risk for OM in conversations about appropriate opioid use, 2) screen and 3) assess these patients for OM and, 4) refer patients for further treatment if OM is suspected. The investigators will employ a modified Delphi approach to iteratively refine and operationalize the procedures and to arrive at a finalized procedure manual followed by an evaluation of the implementation of these procedures. Approximately 4 months following the development of the manual and the distribution of the finalized manual, the investigators will conduct semi-structured interviews to determine the barriers and facilitators to implementing the procedures learned in the training.
Our aims are:
- Qualitatively evaluate physical therapists' perceptions and recommendations for implementing OM procedures.
- Evaluate the implementation of the manualized OM procedures.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Contact
- Name: John Magel, PhD
- Phone Number: 801 673 8973
- Email: jake.magel@hsc.utah.edu
Study Locations
-
-
Utah
-
Salt Lake City, Utah, United States, 84108
- University of Utah
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- University of Utah physical therapists with at least 0.5 full-time equivalent
- Self report managing patients with musculoskeletal pain
Exclusion Criteria:
- None
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Training Arm
|
The training will be composed of 4 separate training sessions provided every 2 - 4 weeks.
During the 1st session (45 minutes), the investigators will educate the physical therapist about the different categories of opioid use including opioid misuse (OM) and the risks associated with OM as well as training to engage the patient in a conversation about opioid use.
The 2nd and 3rd sessions (30 minutes each) involve training in procedures to screen and assess patients at risk for OM, respectively.
The 4th session (30 minutes) involves training in procedures to refer patients to a specialist or a primary care provider for further treatment if OM is suspected.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Change in the Drug and Drug Problems Perception Questionnaire (DDPPQ)
Time Frame: Baseline, immediate post training, 4 months after last training session
|
The DDPPQ is a 20 item tool used to measure the attitudes of health care providers related to the management of patients misusing drugs and contains 5 subscales (Role Adequacy: 7 items; Role Legitimacy: 2 items; Role Support: 3 items; Role Self-esteem: 4 items; Job Satisfaction: 4 items) Each item is scored on a 7-point scale (1 = strongly agree to 7 = strongly disagree).
Each item was modified to asses the health care providers' attitudes about managing patients with opioid misuse.
|
Baseline, immediate post training, 4 months after last training session
|
Other Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Thematic analysis from semi-structured interviews
Time Frame: 4 months after the last training session
|
Semi-structured interviews to assess barriers and facilitators of implementing the procedures learned in the training
|
4 months after the last training session
|
Reach
Time Frame: Immediate post training
|
Proportion of physical therapists who agreed to attend the training that attended all training sessions
|
Immediate post training
|
Adoption 1- engaging patients in conversations
Time Frame: Approximately 4 months after last training session
|
Percentage of physical therapists who attended the training that report engaging patients in conversations about opioid misuse,
|
Approximately 4 months after last training session
|
Adoption 2 - screening
Time Frame: Approximately 4 months after last training session
|
Percentage of physical therapists who attended the training that report screening for opioid misuse
|
Approximately 4 months after last training session
|
Adoption 3 - assessing
Time Frame: Approximately 4 months after last training session
|
Percentage of physical therapists who attended the training that report assessing patients for opioid misuse
|
Approximately 4 months after last training session
|
Adoption 4 - referring
Time Frame: Approximately 4 months after last training session
|
Percentage of physical therapists who attended the training that report referring for opioid misuse
|
Approximately 4 months after last training session
|
Qualitative thematic analysis of each focus group
Time Frame: Immediately after each of the 4 training sessions.
|
The investigators will conduct focus groups after each training session.
All sessions will be analyzed together to qualitatively assess the physical therapists' receptivity to the procedures learned in the training sessions.
|
Immediately after each of the 4 training sessions.
|
Change in the Frequency of opioid misuse management practices - Adapted from the Alcohol Education Survey
Time Frame: Baseline, immediately post training and to approximately 4 months after the last training session
|
Questions were adapted: "How often do you ask patients about alcohol problems?"
was modified to: "How often do you ask patients about problems with prescription opioid medication misuse? 4 additional questions were similarly modified ([1] How often do you formally screen patients for prescription opioid medication misuse using screening instruments, such as the Current Opioid Misuse Measure or other tools; [2] How often do you assess patients' readiness to change their prescription opioid medication misuse behaviors?; [3] How often do you discuss/advise patients to change their prescription opioid medication misuse behaviors?; [4] How often do you refer patients with prescription opioid medication misuse for further assessments or interventions?).
Scoring: Never, Rarely (less than 10% of the time), Occasionally (about 30% of the time), Sometimes (about 50% of the time), Frequently (about 70% of the time), Usually (about 90% of the time), Every time.
|
Baseline, immediately post training and to approximately 4 months after the last training session
|
Manual of procedures
Time Frame: Approximately 4 months after the last training session.
|
At the end of the study after the individual interviews, the investigators will finalize the manual of opioid misuse procedures for physical therapists.
|
Approximately 4 months after the last training session.
|
Change in the Confidence in opioid misuse management practices. Adapted from the Alcohol Education Survey
Time Frame: Baseline, immediately post training and to approximately 4 months after the last training session
|
These questions were adapted from a survey developed to improve health care providers' management of patients with alcohol problems.
The questions are: ([1] I am confident in my ability to ask patients about prescription opioid medication misuse, [2] I am confident in my ability to formally screen patients for prescription opioid medication misuse using screening instruments, such as the Current Opioid Misuse Measure or other tools; [3] I am confident in my ability to assess patients' readiness to change their prescription opioid medication misuse behaviors; [4] I am confident in my ability to discuss/advise patients to change their prescription opioid medication misuse behaviors; [5] I am confident in my ability to refer patients with prescription opioid medication misuse for further assessments or interventions?).
Each confidence with management practice question was scored on a 7-point Likert scale (1 = no confidence; 7 = high confidence).
|
Baseline, immediately post training and to approximately 4 months after the last training session
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: John Magel, PhD, University of Utah
Publications and helpful links
General Publications
- D'Onofrio G, Nadel ES, Degutis LC, Sullivan LM, Casper K, Bernstein E, Samet JH. Improving emergency medicine residents' approach to patients with alcohol problems: a controlled educational trial. Ann Emerg Med. 2002 Jul;40(1):50-62. doi: 10.1067/mem.2002.123693.
- Watson H, Maclaren W, Kerr S. Staff attitudes towards working with drug users: development of the Drug Problems Perceptions Questionnaire. Addiction. 2007 Feb;102(2):206-15. doi: 10.1111/j.1360-0443.2006.01686.x.
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 3394
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
IPD Plan Description
Data to be shared: Individual participant data that underlie the results reported in this article, after deidentification (text, tables, figures, and appendices).
What documents will be available: Study protocol, statistical analysis plan, Analytic code.
With whom will the data be shared: Researchers who provide a methodologically sound proposal
For what type of analyses: To achieve the aims in approved proposal
IPD Sharing Time Frame
IPD Sharing Access Criteria
IPD Sharing Supporting Information Type
- STUDY_PROTOCOL
- SAP
- ANALYTIC_CODE
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Musculoskeletal Pain
-
Sykehuset i Vestfold HFActive, not recruitingBack Pain | Musculoskeletal Pain | Chronic Pain | Musculoskeletal Diseases or Conditions | Pain, Chronic | Musculoskeletal Disorder | Musculoskeletal Neck PainNorway
-
University of Missouri, Kansas CityTerminatedOrthopaedic Related Pain (Musculoskeletal Pain)United States
-
Uppsala UniversityDalarna County Council, Sweden; Center for Clinical Research Dalarna, Sweden; REHSAM, SwedenTerminatedMusculoskeletal Neck Pain | Musculoskeletal Shoulder PainSweden
-
NORCE Norwegian Research Centre ASHelse Sor-Ost; Sykehuset i Vestfold HFCompletedNeck Pain Musculoskeletal | Back Pain Lower BackNorway
-
Massachusetts General HospitalOrthopaedic Trauma AssociationCompleted
-
Stanford UniversityNational Institute of Neurological Disorders and Stroke (NINDS)RecruitingPain | Joint Pain | Pain, Chronic | Chronic Musculoskeletal PainUnited States
-
University of North Carolina, Chapel HillYale University; Duke University; National Institute on Aging (NIA); Indiana University and other collaboratorsCompletedChronic Pain | Acute Musculoskeletal PainUnited States
-
Wayne State UniversityUniversity of Southern CaliforniaCompleted
-
Wayne State UniversityUniversity of MichiganCompleted
Clinical Trials on Training Arm
-
Philippe TerrierSwiss National Science FoundationRecruiting
-
University of ManitobaCanadian Institutes of Health Research (CIHR)CompletedAnterior Cruciate Ligament InjuryCanada
-
National Taiwan University HospitalRecruiting
-
VA Office of Research and DevelopmentTerminated
-
Vejle HospitalTerminated
-
Chang Gung Memorial HospitalNational Science Council, Taiwan; National Health Research Institutes, TaiwanCompletedCerebrovascular AccidentTaiwan
-
University of LouisvilleCompleted
-
Massachusetts General HospitalDana Foundation, Spaulding Rehabilitation HospitalTerminatedStroke | Upper Extremity ParesisUnited States
-
Blythedale Children's HospitalActive, not recruitingCerebral Palsy | Hemiplegia | Acquired Brain Injury | HemiparesisUnited States
-
Robert L. SainburgEunice Kennedy Shriver National Institute of Child Health and Human Development... and other collaboratorsCompleted